{"id":"60f7a1ebf553","type":"article","url":"https://hartvaat.nl/2023/05/02/gepersonaliseerde-beslisondersteuning-verhoogt-statinegebruik-bij-ascvd/","title":"Gepersonaliseerde beslisondersteuning verhoogt statinegebruik bij ASCVD","title_en":"Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease.","category":"cholesterol","category_label":"Cholesterol","professions":["apotheker","cardioloog","huisarts"],"tags":["stress-psychosociaal","vrouwen"],"journal":"Circulation","doi":"10.1161/CIRCULATIONAHA.123.064226","source_url":"https://doi.org/10.1161/CIRCULATIONAHA.123.064226","authors":["Salim S Virani","David J Ramsey","Dax Westerman","Mark K Kuebeler","Liang Chen","Julia M Akeroyd","Glenn T Gobbel","Christie M Ballantyne","Laura A Petersen","Alexander Turchin","Michael E Matheny"],"significance":6,"published":"2023-05-02","source_date":"2023-05-02","image":"","kennis":["https://hartvaat.nl/kennis/lipiden/lpa-meten-wanneer-waarom/","https://hartvaat.nl/kennis/lipiden/dyslipidemie-overzicht/"],"congress":"","summary_en":"This cluster-randomized trial showed that personalized clinical decision support significantly increases statin prescribing in patients with established ASCVD, demonstrating the effectiveness of AI-assisted prescribing prompts.","created":"2026-07-03T10:30:21Z","updated":"2026-07-03T13:29:25Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Cluster-RCT toonde dat gepersonaliseerde klinische beslisondersteuning het statinegebruik bij ASCVD-patiënten significant verhoogde. De interventie integreerde patiëntspecifieke risicoinformatie in het voorschrijfproces.","abstract_original":""}